London
· Delayed Price · Currency is GBP · Price in USD Cardinal Health Statistics
Total Valuation
Cardinal Health has a market cap or net worth of GBP 26.85 billion. The enterprise value is 30.94 billion.
| Market Cap | 26.85B |
| Enterprise Value | 30.94B |
Important Dates
The last earnings date was Thursday, May 1, 2025.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Jul 1, 2025 |
Share Statistics
| Current Share Class | 238.68M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.11% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 237.37M |
Valuation Ratios
The trailing PE ratio is 22.28 and the forward PE ratio is 16.52.
| PE Ratio | 22.28 |
| Forward PE | 16.52 |
| PS Ratio | 0.16 |
| PB Ratio | -18.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.33, with an EV/FCF ratio of 16.36.
| EV / Earnings | 25.68 |
| EV / Sales | 0.18 |
| EV / EBITDA | 12.33 |
| EV / EBIT | 17.05 |
| EV / FCF | 16.36 |
Financial Position
The company has a current ratio of 0.94
| Current Ratio | 0.94 |
| Quick Ratio | 0.44 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.32 |
| Debt / FCF | 3.14 |
| Interest Coverage | 13.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 3.13% |
| Return on Invested Capital (ROIC) | 35.80% |
| Return on Capital Employed (ROCE) | 18.15% |
| Revenue Per Employee | 3.55M |
| Profits Per Employee | 24,893 |
| Employee Count | 48,900 |
| Asset Turnover | 4.64 |
| Inventory Turnover | 12.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +51.75% in the last 52 weeks. The beta is 0.63, so Cardinal Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +51.75% |
| 50-Day Moving Average | 134.40 |
| 200-Day Moving Average | 120.58 |
| Relative Strength Index (RSI) | 67.60 |
| Average Volume (20 Days) | 362 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.98 |
Income Statement
In the last 12 months, Cardinal Health had revenue of GBP 172.05 billion and earned 1.21 billion in profits. Earnings per share was 4.94.
| Revenue | 172.05B |
| Gross Profit | 6.07B |
| Operating Income | 1.86B |
| Pretax Income | 1.63B |
| Net Income | 1.21B |
| EBITDA | 2.45B |
| EBIT | 1.86B |
| Earnings Per Share (EPS) | 4.94 |
Balance Sheet
The company has 2.57 billion in cash and 5.94 billion in debt, giving a net cash position of -3.37 billion.
| Cash & Cash Equivalents | 2.57B |
| Total Debt | 5.94B |
| Net Cash | -3.37B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.47B |
| Book Value Per Share | -9.55 |
| Working Capital | -1.60B |
Cash Flow
In the last 12 months, operating cash flow was 2.28 billion and capital expenditures -393.19 million, giving a free cash flow of 1.89 billion.
| Operating Cash Flow | 2.28B |
| Capital Expenditures | -393.19M |
| Free Cash Flow | 1.89B |
| FCF Per Share | n/a |
Margins
Gross margin is 3.53%, with operating and profit margins of 1.08% and 0.70%.
| Gross Margin | 3.53% |
| Operating Margin | 1.08% |
| Pretax Margin | 0.95% |
| Profit Margin | 0.70% |
| EBITDA Margin | 1.42% |
| EBIT Margin | 1.08% |
| FCF Margin | 1.10% |
Dividends & Yields
This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 1.06%.
| Dividend Per Share | 1.58 |
| Dividend Yield | 1.06% |
| Dividend Growth (YoY) | -0.91% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 31.86% |
| Buyback Yield | 2.11% |
| Shareholder Yield | 3.17% |
| Earnings Yield | 4.49% |
| FCF Yield | 7.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardinal Health has an Altman Z-Score of 4.9.
| Altman Z-Score | 4.9 |
| Piotroski F-Score | n/a |